Orin
CAGNYSE·Packaged Foods

Conagra Brands, Inc. CAG

Market cap $6.9BP/E —no earnings to divide byGross margin 23.9%Reports Wed 30 Sep, before the open
$14.36
−0.31 (−2.11%)live 11:25 ET
52-wk $12.53 – $20.32
Watch
Orin's take
0.62conviction · moderate
Refreshed 24 Sep · take v7. A new filing or a print queues the next refresh.

Conagra Brands is a sell as the fundamental deterioration outpaces balance-sheet repair. FY2026 (ended 2026-05-31) produced a $1.63B operating loss and EPS of -$4.00, gross margin compressed to 23.92% from 25.86%, and revenue fell for a fourth consecutive year to $11.28B.

While debt was reduced to $7.27B from $8.07B and free cash flow held at $978.7M, the stock at $14.78 trades below both its 50-day ($15.25) and 200-day ($15.72) moving averages with a bearish MACD histogram (-0.084) and RSI at 40.2, signaling deteriorating momentum alongside declining fundamentals.

What could go wrong

  • Impairment distortion. The FY2026 operating loss of -$1.63B was concentrated in Q4 (-$2.63B operating loss vs +$280M in Q3), suggesting large non-cash impairment charges that may not recur, making underlying earnings power better than headline figures imply.
  • Q1 FY2027 earnings catalyst. Conagra reports Q1 earnings on Sept 30, 2026; a beat or positive guidance from CEO Brase's growth plan could reverse bearish technicals quickly.
  • Deleveraging progress. Total debt fell from $8.07B to $7.27B and FCF of $978.7M supports continued deleveraging, which could attract value investors if revenue stabilizes.
  • Valuation floor. PS ratio of 0.627 is roughly in line with peer median (0.621), and with positive FCF, the stock may have limited downside if the market views impairments as one-time.

What would change my mind

Q1 FY2027 earnings beat with margin stabilization. Q1 FY2027 report on Sept 30 shows gross margin recovery above 25% and positive organic revenue growthbullish
Continued institutional selling. Additional major holders reduce positions following State Street's 33.9% cut, or smart money score falls below zerobearish
Revenue growth confirmation. Two consecutive quarters of positive YoY revenue growth, building on Q4 FY2026's +3.6%bullish
Further gross margin compression. Gross margin falls below 23% in upcoming quarters, indicating cost pressures exceeding pricing powerbearish

Where this comes from: FMP annual fundamentals, fiscal year ended 2026-05-31 · derived_metrics, FY2026 vs FY2025 · FMP annual fundamentals, FY2022-FY2026 revenue trend · FMP annual fundamentals, FY2026 vs FY2025. Orin's read on CAG; not advice.

Twelve months actual closes to 2026-09-24 · actual filings

Sept 25Nov 25Jan 26Mar 26May 26Jul 26

50-day average 200-day average · volume below

Largest holders · 13F Q2 2026

Money flow
FilerPositionOf fund
Vanguard Portfolio Management$393.1M0.0% of fund
Vanguard Capital Management$290.3M0.0% of fund
Aqr Capital Management$275.9M0.1% of fund
State Street$222.6M0.0% of fund
Two Sigma Investments$177.5M0.1% of fund
Goldman Sachs Group$167.6M0.0% of fund

77 filers · quarter ended Q2 2026 · positions, not flows

Insiders, last 24 months: 221 Form 4 filings, net −$8.8M. Of the 50 on hand, none was an open-market trade— the rest are grants, option exercises and tax withholding.

Ask Orin about CAG

its filings · its transcripts · its numbers

Orin answers questions about CAG from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

Start 3 free days →

Where it trades

vs its own 5y · Consumer Defensive
MetricNowOwn medianSector
P/S0.62×1.36×—
P/B1.1×1.8×—

Its P/E sits below all 5 of the last 5 years (−2.24σ from its own mean).

What the price assumes

-6.6%

free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $1.0B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.

What Wall Street published

25 firms · 2026-09-24
Consensus target

$14

$12 – $16 · −3% against today's price

How they rate it
  • 6 buy or overweight
  • 15 hold
  • 4 underweight or sell

The analysts’ consensus and their own ratings, not Orin’s. A target is a twelve-month opinion published by the firm that wrote it.

Against the companies it is compared to

median P/E 14.8× of 1 peers
CompanyMarket capP/EEV/EBITDAGrossNetROE
CAGConagra Brands, Inc.$7B——23.9%-17.0%-24%
CPBCampbell Soup Company$6B14.8×10.0×28.1%4.1%10%
TAPMolson Coors Beverage Company$7B——36.2%-20.8%-23%

The median is of the 1 peers listed above and nothing else — check it against the column. The peer set is the vendor’s, so a company can appear here that a person would not have chosen.

What it has traded at

P/E by fiscal year
FY17 26.0×FY25 9.3×

What its sector has traded at

Consumer Defensive
FY14 22.9×FY26 39.1×

Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.

Discounted cash flow

not recomputed since
ModelFair valueAgainstComputed
Standard DCF$38$13.31 · +182%2026-06-10
Levered DCF$70$13.31 · +425%2026-06-10

The vendor’s intrinsic-value models. Treat them as a low-growth anchor — for a fast grower the market routinely pays well above a DCF. These were computed against the price in the “against” column, not today’s.

Every estimate on one scale

price $14.36
52-week range$13 – $20
Analyst targets$12 – $16
Standard DCF$38 as of 2026-06-10, when it was $13.31
Levered DCF$70 as of 2026-06-10, when it was $13.31

The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.